BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25912399)

  • 1. Heparanase is a host enzyme required for herpes simplex virus-1 release from cells.
    Hadigal SR; Agelidis AM; Karasneh GA; Antoine TE; Yakoub AM; Ramani VC; Djalilian AR; Sanderson RD; Shukla D
    Nat Commun; 2015 Apr; 6():6985. PubMed ID: 25912399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus 2 Release from Cells.
    Hopkins J; Yadavalli T; Agelidis AM; Shukla D
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress.
    Hadigal S; Koganti R; Yadavalli T; Agelidis A; Suryawanshi R; Shukla D
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31827001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic Heparanase Inhibitors Can Prevent Herpes Simplex Viral Spread.
    Chopra P; Yadavalli T; Palmieri F; Jongkees SAK; Unione L; Shukla D; Boons GJ
    Angew Chem Int Ed Engl; 2023 Oct; 62(41):e202309838. PubMed ID: 37555536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase, Heparan Sulfate and Viral Infection.
    Agelidis A; Shukla D
    Adv Exp Med Biol; 2020; 1221():759-770. PubMed ID: 32274736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Heparanase and Syndecan-1 in HSV-1 Release from Infected Cells.
    Sharma P; Kapoor D; Shukla D
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease, Growth Factor, and Heparanase-Mediated Syndecan-1 Shedding Leads to Enhanced HSV-1 Egress.
    Karasneh GA; Kapoor D; Bellamkonda N; Patil CD; Shukla D
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase-Induced Activation of AKT Stabilizes β-Catenin and Modulates Wnt/β-Catenin Signaling during Herpes Simplex Virus 1 Infection.
    Koujah L; Madavaraju K; Agelidis AM; Patil CD; Shukla D
    mBio; 2021 Dec; 12(6):e0279221. PubMed ID: 34749529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.
    Tiwari V; Liu J; Valyi-Nagy T; Shukla D
    J Biol Chem; 2011 Jul; 286(28):25406-15. PubMed ID: 21596749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparanase Upregulation Contributes to Porcine Reproductive and Respiratory Syndrome Virus Release.
    Guo C; Zhu Z; Guo Y; Wang X; Yu P; Xiao S; Chen Y; Cao Y; Liu X
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1.
    Agelidis AM; Hadigal SR; Jaishankar D; Shukla D
    Cell Rep; 2017 Jul; 20(2):439-450. PubMed ID: 28700944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.
    Bender FC; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ
    J Virol; 2005 Sep; 79(18):11588-97. PubMed ID: 16140736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CREB3 Plays an Important Role in HPSE-Facilitated HSV-1 Release in Human Corneal Epithelial Cells.
    Yadavalli T; Sharma P; Wu D; Kapoor D; Shukla D
    Viruses; 2022 May; 14(6):. PubMed ID: 35746643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1.
    Trybala E; Roth A; Johansson M; Liljeqvist JA; Rekabdar E; Larm O; Bergström T
    Virology; 2002 Oct; 302(2):413-9. PubMed ID: 12441085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSV-1 interaction to 3-O-sulfated heparan sulfate in mouse-derived DRG explant and profiles of inflammatory markers during virus infection.
    Sharthiya H; Seng C; Van Kuppevelt TH; Tiwari V; Fornaro M
    J Neurovirol; 2017 Jun; 23(3):483-491. PubMed ID: 28326469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
    Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
    Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells.
    Mårdberg K; Trybala E; Tufaro F; Bergström T
    J Gen Virol; 2002 Feb; 83(Pt 2):291-300. PubMed ID: 11807221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB.
    Zheng K; Chen M; Xiang Y; Ma K; Jin F; Wang X; Wang X; Wang S; Wang Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):990-6. PubMed ID: 24657267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways-Do They Share a Common Ground in Melanoma Cells?
    Hoß SG; Grundmann M; Benkel T; Gockel L; Schwarz S; Kostenis E; Schlesinger M; Ilan N; Vlodavsky I; Bendas G
    Thromb Haemost; 2018 Oct; 118(10):1803-1814. PubMed ID: 30235481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1.
    Xu D; Tiwari V; Xia G; Clement C; Shukla D; Liu J
    Biochem J; 2005 Jan; 385(Pt 2):451-9. PubMed ID: 15303968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.